id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0280-0005,FDA,FDA-2006-P-0280,"Background Materials re: Citizen Petition from Lachman Consultant Services, Inc.- Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations, Electronic Orange Book listing Accessed December 6, 2006",Supporting & Related Material,Background Material,2008-11-19T05:00:00Z,2008,11,,,2024-12-10T18:28:32Z,,0,0,09000064804585da
FDA-2006-P-0280-0006,FDA,FDA-2006-P-0280,"Background Materials re: Citizen Petition from Lachman Consultant Services, Inc. - Attachment 4 - List of products approved in Electronic Orange Book with 400 mg dosage strength of Acetaminophen",Supporting & Related Material,Background Material,2008-11-19T05:00:00Z,2008,11,,,2024-12-10T18:29:28Z,,0,0,09000064804585e0
FDA-2006-P-0280-0003,FDA,FDA-2006-P-0280,"Citizen Petition from Lachman Consultant Services, Inc",Other,Citizen Petition,2008-11-19T05:00:00Z,2008,11,2008-11-19T05:00:00Z,,2024-12-10T18:25:17Z,,0,0,09000064804585d8
FDA-2006-P-0280-0004,FDA,FDA-2006-P-0280,"Background Materials re: Citizen Petition from Lachman Consultant Services, Inc. - Attachment 2 - Approved labeling for Reference-Listed Drug Product (RLD), Darvocet-N 1000 Tablets (Xanodyne), Rev. 07-2004",Supporting & Related Material,Background Material,2008-11-19T05:00:00Z,2008,11,,,2024-12-10T18:27:35Z,,0,0,09000064804585d0